Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Petrick, Joy Kristin

Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), which mostly affects underprivileged populations in South and Central America. The current standard of care for this disease are the two empirically discovered drugs benznidazole and nifurtimox. They show low efficacy, diffi...

Täydet tiedot

Tallennettuna:

Bibliografiset tiedot
Päätekijä:	Petrick, Joy Kristin
Muut tekijät:	Klebe, Gerhard (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Aineistotyyppi:	Dissertation
Kieli:	englanti
Julkaistu:	Philipps-Universität Marburg 2019
Aiheet:	Pharmakologie, Therapeutik mevalonate farnesyl pyrophosphate kissing bug Isoprenoid FPPS Fragment-basierte Wirkstoffforschung FDPS Chagas disease Chagas fragment based drug discovery Protein-Kristallograph protein cry isoprenoid Vernachlässigte Krankheit Farnesylpyroposphate-Synthase neglected disease Pharmacology & therapeutics, prescription drugs
Linkit:	PDF-kokoteksti
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Lisää ensimmäinen kommentti!

Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Samankaltaisia teoksia